Bavarian Nordic A/S
Industry
- Pharmaceuticals
- Drug Delivery
- Macromolecule
- Vaccines
- Drug Delivery
- Biotechnology
- Large Molecule
Latest on Bavarian Nordic A/S
Pandemic Anniversary Resonates Within a few days of the fifth anniversary of the declaration of the COVID-19 pandemic by the World Health Organization, the first quarter of 2025 headed towards its clo
The newly rescheduled meeting of the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) will be shorter than the delayed February meeting, likely refle
Two years almost to the day after Bavarian Nordic acquired a portfolio of travel vaccine candidates from Emergent BioSolutions, that investment has paid off with the US Food and Drug Administration ap
The US Food and Drug Administration’s approval of two new vaccines places the spotlight on what would normally be a routine next step on the road to market, the US Center for Disease Control and Preve